Certain formulations for four of the first ten drugs selected for Medicare drug price negotiations have newly negotiated prices lower [...] …
Category: Regulatory
Two major hospital advocacy groups are urging the federal agency that oversees the 340B program to “take immediate enforcement action” [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Johnson & Johnson’s (J&J’s) proposed 340B rebate model, which has not received government approval, would give the drugmaker significantly more [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Drugmaker Kedrion Biopharma has posted a refund notice to 340B providers, and Mylan notified covered entities of National Drug Code [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The federal agency that oversees the 340B program did not approve drugmaker Johnson & Johnson’s (J&J’s) proposal to convert certain [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
In a move that would fundamentally alter the 340B program, pharmaceutical giant Johnson & Johnson (J&J) told hospitals this morning [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
French drugmaker Sanofi has reportedly asked some hospitals for data relating to 340B purchases of a popular drug used to [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Six national hospital associations recently urged the Supreme Court to correct what they called the Department of Health and Human [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A federal court last week sided with a group of Texas hospitals’ efforts to block—at least temporarily—a Department of Health [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A major hospital advocacy group recently urged congressional advisers to “carefully consider” the potential negative consequences of any new efforts [...] …